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The essential oils (EO) and bioactive fractions (BF) fromAloysia gratissima, Baccharis dracunculifolia, Coriandrum sativum, Cyperus
articulatus, and Lippia sidoides were proven to have strong antimicrobial activity on planktonic microorganisms; however, little is
known about their effects on the morphology or viability of oral biofilms. Previously, we determined the EO/fractions with the best
antimicrobial activity against Streptococcus mutans and Candida spp. In this report, we used a confocal analysis to investigate the
effect of these EO and BF on the morphology of S. mutans biofilms (thickness, biovolume, and architecture) and on the metabolic
viability of C. albicans biofilms. The analysis of intact treated S. mutans biofilms showed no statistical difference for thickness in all
groups compared to the control. However, a significant reduction in the biovolume of extracellular polysaccharides and bacteria was
observed forA. gratissima and L. sidoides groups, indicating that these BF disrupt biofilm integrity andmay have created porosity in
the biofilm.This phenomenon could potentially result in a weakened structure and affect biofilm dynamics. Finally, C. sativum EO
drastically affected C. albicans viability when compared to the control. These results highlight the promising antimicrobial activity
of these plant species and support future translational research on the treatment of dental caries and oral candidiasis.
1. Introduction
It has been long known that biofilms formed by Streptococcus
mutans and Candida albicans are implicated in the establish-
ment of dental caries and oral candidiasis, respectively, and
constitute complex structures, often composed of interactive
microorganisms which are organized for increasedmetabolic
efficiency, resistance to stress, and virulence [1] with a sophis-
ticated quorum sensing system [2].
Extracellular polysaccharides (EPS) produced by S.
mutans glycosyltransferases are the main constituents in the
matrix of cariogenic biofilms and are recognized as critical
virulence factors associated with dental caries [3]. An EPS-
rich matrix creates highly adhesive, interconnected, and
acidic environments, which ultimately leads to the clinical
onset of cavitation through acid demineralization of the
adjacent enamel [4]. The EPS matrix provides a three-
dimensional scaffold for biofilm development and assembly,
which confers increased resistance to antimicrobials and cre-
ates signaling pathways [3].
Biofilm formation on host tissues or medical devices
mediated either by biotic (cell-surface proteins) or abiotic
(surface hydrophobicity) factors also plays a role in the patho-
genesis of yeast infections [5].
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Table 1: Ethnobotanical characterization of the plant species used in this study.
Family Botanical name Source CPMA registration number∗ Folk name
Verbenaceae Aloysia gratissima leaf 714 Brazilian lavender
Asteraceae Baccharis dracunculifolia DC leaf 1841 Broom weed
Apiaceae Coriandrum sativum L. leaf 664 Coriander
Cyperaceae Cyperus articulatus Vahl. bulbs 222 Priprioca
Verbenaceae Lippia sidoides Cham. leaf 398/399 Rosemary
∗Website: http://webdrm.cpqba.unicamp.br/cpma/banco de dados/index.php?centro=catalogo.
Therefore, the development of specific-targeted therapies
attenuating microbial virulence is of utmost importance and
thus contributing to themanagement of dental caries and oral
candidiasis, which have considerably affected the population
worldwide [6, 7]. With this perspective, essential oils (EO)
have been shown to be effective antimicrobial agents against
a number of gram-positive bacteria and yeasts. They are
complex, volatile compounds produced by aromatic plants
as secondary metabolites [8], and the presence of complex
chemical structures thereof may explain their antimicrobial
effects upon biofilms of clinical relevance.
In our previous studies, we screened twenty EO and their
bioactive fractions and selected those with the most promis-
ing antimicrobial activity against S. mutans [9] and Candida
spp. [10, 11] as follows: Aloysia gratissima (fraction Ag
4
),
Baccharis dracunculifolia (fractionBd
2
),Coriandrum sativum
(EO and fraction Cs
4
), Lippia sidoides (fraction Ls
3
), and
Cyperus articulatus (EO). In general, Cs
4
and Bd
2
inhibited
more than 90% of in vitro S. mutans biofilm formation at low
concentrations (31.2𝜇g/mL), followed by Ag
4
(62.5𝜇g/mL)
and Ls
3
(125 𝜇g/mL) [9]. The EO from C. sativum and C.
articulatus inhibited C. albicans biofilm from 62.5𝜇g/mL [11]
and 1.95 𝜇g/mL [10], respectively. Furthermore, these studies
have demonstrated by scanning electronmicroscopy analysis
that the EO disrupt biofilm integrity, but little is known about
the effect of these EO on the architectural structure and
viability of oral biofilms.
Thus, based on these previous results and on the relevance
of discovering new agents for the management of biofilm-
dependent diseases, we investigated through a confocal
analysis the effect of the EO and bioactive fractions earlier
mentioned on the morphology of S. mutans biofilms by
assessing thickness, biovolume, and architecture and on the
metabolic viability of C. albicans biofilms.
2. Material and Methods
2.1. Plant Material. Plant species were obtained from the
germoplasm bank of the Collection of Medicinal and
Aromatic Plants (CPMA) at the Research Center for
Chemistry, Biology, and Agriculture (CPQBA), Univer-
sity of Campinas (UNICAMP), SP, Brazil (available at
http://webdrm.cpqba.unicamp.br/cpma/).The plantmaterial
was collected between November and January, during the
morning. Voucher specimens were deposited in the herbar-
ium of the Institute of Biology at the University of Campinas
(Campinas, SP, Brazil) and also registered in the herbarium
of CPQBA, receiving identification numbers (Table 1).
2.2. Essential Oil Extraction and Fractionation. The EO were
obtained through hydrodistillation of the leaves or bulbs
for 3 hours in a Clevenger-type system. The aqueous phase
was extracted with dichloromethane and the organic layer
was then isolated, dried with anhydrous sodium sulphate
(Na
2
SO
4
) to remove any trace of water, and filtered.This step
is critical to absorb remaining moisture in the organic phase,
resulting in water-free oil content. The solvent was finally
evaporated to obtain the crude EO [12]. The EO were stored
at −20∘C in amber glass vials to be subsequently fractionated.
Emulsions of the fractions or crude oils were prepared
using propylene glycol (v/v) as vehicle before undergoing
microbiological testing.
The EO were fractionated using the dry column method
(cellulose column2 cm× 20 cm)with Si gel 60 (Merck,Darm-
stadt, Germany) as the stationary phase and dichloromethane
as the mobile phase, previously chosen by Thin Layer
Chromatography. After elution, columns were separated into
different parts for each EO based on polarity. The frac-
tions obtained were chemically characterized by Thin Layer
Chromatography and Gas Chromatography coupled to Mass
Spectrometry (GC-MS) and tested for their antimicrobial
activity. The selected EO and bioactive fractions showing
the best antibacterial/antifungal effects (previously found by
Galva˜o et al. [9] and Freires et al. [11]) are listed as follows:
A. gratissima (fraction Ag
4
), B. dracunculifolia (fraction Bd
2
),
C. sativum (fraction Cs
4
and EO), C. articulatus (EO), and L.
sidoides (fraction Ls
3
).
All chemical wastes generated in this study were treated
in accordance with the principles of the Environmental
Ethics Board at the University of Campinas, SP, Brazil, under
protocol number 324/2009.
2.3. Phytochemical Analysis of the Essential Oils and Bioactive
Fractions by Gas Chromatography Coupled to Mass Spectrom-
etry (GC-MS). Volatile constituents were identified using a
Hewlett-Packard 6890 gas chromatograph coupled with an
HP-5975 mass selective detector and HP-5 capillary column
(30m × 0.25mm × 0.25 𝜇m diameter). GC-MS analysis was
performed using split injection (40 : 1), with the injector set
at 220∘C, column set at 60∘C, with a heating ramp of 3∘C/min
and a final temperature of 240∘C, and the MS detector set at
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Table 2: Concentration of the bioactive fractions and crude oils tested in this bioguided study against S. mutans and C. albicans, respectively.
Plant species Sample Microorganism Concentration
A. gratissima Fraction Ag4 S. mutans UA 159 800 𝜇g/mL
B. dracunculifolia Fraction Bd2 S. mutans UA 159 600𝜇g/mL
L. sidoides Fraction Ls3 S. mutans UA 159 800 𝜇g/mL
C. sativum Fraction Cs4 S. mutans UA 159 600𝜇g/mL
C. sativum Crude oil C. albicans CBS 562 600𝜇g/mL
C. articulatus Crude oil C. albicans CBS 562 800 𝜇g/mL
250∘C.Heliumwas used as a carrier gas at 1mL/min.TheGC-
MS electron ionization system was set at 70 eV. Samples of
the bioactive fraction or crude oil were solubilized in ethyl
acetate for the analysis. Then, retention indices (RIs) were
determined by coinjection of hydrocarbon standards (alkanes
C
8
–C
30
) and test samples under the same conditions. The
oil components were identified by comparison with the data
from the NIST 05 library, international literature, and by
coinjection of authentic standards [11, 13].
2.4. Preparation of S. mutans and C. albicans Suspensions.
Reference strains of S. mutans UA 159 (ATCC 700610,
serotype c) and C. albicans CBS 562 were used.
A starter culture of S. mutanswas prepared using ultrafil-
tered (10 kDa cutoff membrane; Prep/Scale; Millipore, MA)
tryptone yeast extract (UFTYE, pH 7.0) supplemented with
1% (w/v) glucose, incubated at 37∘C, 5% CO
2
, overnight.This
starter was used to prepare bacterial inoculum at midexpo-
nential growth phase for biofilm formation (OD
600 nm, 2 × 10
6
CFU/mL) (adapted from da Cunha et al. [14]).
C. albicans was grown in yeast nitrogen base (YNB)
(Himedia, Mumbai, India) supplemented with 50mM glu-
cose. Fifty millimeters of medium was inoculated with yeast
colonies from Sabouraud Dextrose Agar (Himedia, Mumbai,
India) plates, followed by incubation for 24 h at 37∘C. Cells
were harvested (1200 rpm, 10 minutes, 10∘C), washed twice
with 0.15M phosphate-buffered saline (pH 7.2, Ca2+- and
Mg2-free), resuspended in 40mL of PBS, and read on spec-
trophotometer to have a concentration of 5 × 106 CFU/mL
(530 nm, 𝜆 = 0.08–0.1) (adapted from Kuhn et al. [15]).
2.5. Preparation and Treatment of Biofilms. S. mutans bio-
films were developed on saliva-coated glass slides (surface
area 324mm2) immersed in 12-well flat-bottom cell culture
plates (TPP, Trasadingen, Switzerland) in triplicate. Human
whole saliva was collected from two donors (Research
Ethics Committee, Piracicaba Dental School, University of
Campinas, protocol #087/2011), clarified by centrifugation
(10000 g, 4∘C, 10min), sterilized and diluted (1 : 1) in adsorp-
tion buffer (AB; 50mM KCl, 1mM KPO
4
, 1 mM CaCl
2
,
0.1mMMgCl
2
, pH 6.5), and supplemented with the protease
inhibitor phenylmethylsulfonyl-fluoride (PMSF) at a final
concentration of 1mmol/L. The glass slides were placed as
much vertically as possible in 12-well plates and inoculated
with S. mutans suspension in buffered ultrafiltered UFTYE
medium supplemented with 1% (w/v) sucrose and incubated
at 37∘C, 5% CO
2
. S. mutans biofilms were grown undisturbed
during 19 h, and later the culture medium was replaced daily
until the end of the experimental period, which totalized
72 h (adapted from da Cunha et al. [14]). To assess the effect
of the bioactive fractions on S. mutans biofilm formation,
the 19-hour-old biofilms were treated for two days (10 a.m.
and 4 p.m., total of 4 treatments with 1 minute exposure per
treatment) with the bioactive fractions or vehicle (propylene
glycol) at the given concentrations (Table 2), both diluted in
sterile AB buffer. On the third day (72 h), the samples were
prepared for confocal laser scanning analysis.
For preparation of C. albicans biofilms, glass slides
(324mm2 surface area) were initially immersed in 12-well
flat-bottom cell culture plates (TPP, Trasadingen, Switzer-
land) containing fetal bovine serum (FBS) (Vitrocell Embri-
olife, Campinas, SP, Brazil) and incubated aerobically for
24 h at 37∘C (pretreatment phase). The slides were then
washed with PBS to remove residual FBS, moved to new
plates containing a standardized C. albicans suspension (5 ×
106 CFU/mL) and incubated aerobically for 90 minutes at
37∘C (adhesion phase). The slides were gently transferred to
new plates to ensure the removal of nonadhered yeasts and
were finally immersed in YNB medium containing the EO
(Table 2), vehicle (propylene glycol), and standard antifungal
(nystatin—7.8𝜇g/mL (MIC); Sigma-Aldrich, St. Louis, MO,
USA), in triplicate. The plates were incubated aerobically at
37∘C for 48 h (biofilm formation phase) (adapted from Kuhn
et al. [15]).
The sample concentrations used in this study were based
on our previous findings of antimicrobial susceptibility for
the bioactive fractions and EO [9, 11]. Samples with plank-
tonic minimum inhibitory concentration (MIC) values rang-
ing from 7.8 to 15.6 𝜇g/mL or 15.7 to 125𝜇g/mL were tested at
600𝜇g/mL and 800𝜇g/mL, respectively, in view of the higher
microbial resistance observed in biofilm cultures [16].
2.6. Confocal Laser Scanning Microscopy (CLSM) Analysis
for S. mutans Biofilms. Extracellular polysaccharides (EPS)
were labeled via incorporation of Alexa Fluor 647 dextran
conjugate (D22914, Life Technologies, Carlsbad, CA, USA)
(absorbance/fluorescence emission maxima of 647/668 nm),
while bacterial cells were stained with SYTO 9 (485/498 nm)
(S34854, Life Technologies, Carlsbad, CA, USA) 30 minutes
before confocal imaging. The analysis of intact biofilms
was performed using a Zeiss LSM 780-NLO confocal laser
scanning microscope (Carl Zeiss AG, Germany) equipped
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Table 3: Major chemical compounds of the selected bioactive fractions and EO identified by GC-MS.
Rt (min)a RIb Major compounds∗ Relative percentage
c
Ag4 Bd2 Ls3 Cs4 CS CA
4.82 933 𝛼-Pinene 7.82
13.06 1140 trans-Pinocarveol 13.16 6.02
15.41 1197 Myrtenol 5.31
15.38 1207 Decanal 19.09
17.74 1263 trans-2-Decenal 17.54
18.59 1271 1-Decanol 16.93
18.15 1272 2-Decen-1-ol 12.33
18.26 1275 Cyclodecane 12.15
19.43 1291 Thymol 93.98 5.17
21.84 1349 Ethyl ester benzenepropanoic 11.7
20.72 1373 𝛼-Copaene 6.79
24.77 1419 trans-Caryophyllene 10.7 9.45
26.19 1467 cis-2-Dodecenal 10.72
26.83 1470 trans-2-Dodecen-1-ol 5.75
26.05 1503 𝛼-Bulnesene 6.87
30.59 1566 trans-Nerolidol 52.2
28.69 1572 Md = 220 6.10
31.02 1577 Spathulenol 11.5 12.39
31.23 1582 Caryophyllene oxide 6.3
31.26 1583 Globulol 12.66
31.92 1601 Guaiol 29.63
33.89 1654 𝛼-Cadinol 5.43
34.41 1669 Bulnesol 11.79
34.02 1671 M = 210 11.51
32.52 1675 Mustakone 6.06
35.06 1747 M = 218 6.48
Notes: aretention time; bretention index; cpercentage fraction of the total area integrated for the chromatogram; dM: molecular weight of a nonidentified
compound. ∗Only the compounds with relative percentage above 5% are listed. Ag4: A. gratissima fraction 4; Bd2: B. dracunculifolia fraction 2; Ls3: L. sidoides
fraction 3; Cs4: C. sativum fraction 4; CS: C. sativum crude oil; CA: C. articulatus crude oil.
with a EC Plan-Neofluar 63x oil immersion objective lens
(excitation wavelength 810 nm). Each biofilm was scanned
at least at 5 randomly selected points and a confocal image
series was generated by optical sectioning (4𝜇m intervals)
at each of the positions [17, 18]. The confocal images stacks
were then analyzed with COMSTAT computer program [19]
in order to quantify and characterize the 3D structure of
the biofilms. The architectural parameters investigated were
biovolume (𝜇m3 ⋅𝜇m−2), average thickness (𝜇m), and biofilm
coverage (𝜇m) on the slide surface.
2.7. CLSM Analysis for C. albicans Biofilms. Following for-
mation and treatment of C. albicans biofilms, the slides
were removed and transferred to a new 12-well plate. Four
microliters of FUN-1 (from a 10mM stock) (F-7030, Life
Technologies, Carlsbad, CA,USA) and 15 𝜇L of Concanavalin
A, Alexa Fluor 488 Conjugate (from a 5-mg/mL stock)
(C11252, Life Technologies, Carlsbad, CA, USA) were mixed
into 3mL of PBS to give final concentrations of 10 𝜇M and
25 𝜇g/mL, respectively, in the wells [15]. The plates were then
incubated for 45min at 37∘C and the slides were subsequently
analyzed on the confocal microscope equipped with a LD
Plan-Neofluar 40x/0.6 water immersion objective lens. Each
biofilmwas scanned at least at 5 randomly selected points and
representative images were selected for each group.
2.8. Statistical Analysis. The data were analyzed qualitatively
based on the morphology and architecture of EPS and bacte-
rial cells and quantitatively by one-way analysis of variance
(ANOVA) followed by Dunnett’s multiple comparison test
(GraphPad Prism version 5.0, San Diego, California, USA)
with type I error set as 0.05. 2D and 3D images were
generated and processed using ZEN2012 Black Edition©Carl
Zeiss Microscopy Gmbh platform. All experiments were
performed in triplicate.
3. Results and Discussion
3.1. Chemical Characterization of Oils and Bioactive Fractions
Constituents. The medicinal aromatic plants were obtained
exclusively from a germoplasm bank (Table 1) and submitted
to chemical monitoring by GC-MS (Table 3), in order to
provide georeferencing and traceability.
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Table 4: Mean values (±SD) of bacterial cells and extracellu-
lar polysaccharides biomass, expressed in 𝜇m3⋅𝜇m−2, of topically
treated biofilms of Streptococcus mutans UA 159.
Group S. mutans cells Exopolysaccharidematrix (EPS)
A. gratissima (Ag4) 15.63 ± 2.56󳶃 14.90 ± 7.73󳶃
B. dracunculifolia (Bd2) 33.41 ± 19.16󳶃 27.99 ± 14.85󳵳
C. sativum (Cs4) 22.83 ± 12.63󳶃 20.49 ± 12.08󳵳
L. sidoides (Ls3) 17.45 ± 4.34󳶃 16.68 ± 7.01󳶃
Vehicle 36.32 ± 32.77 20.00 ± 3.41
Note: the arrow “󳶃” indicates statistically significant reduction of cells or
EPS compared to the control, whereas the arrow “󳵳” indicates statistically
significant increase of cells or EPS compared to the control (one-way
ANOVA with Dunnett’s multiple comparison test, with a significance level
of 5%).
The chemical composition of the EO and selected bioac-
tive fractions can be seen in Table 3. Importantly, the chem-
ical profile of each EO or active fraction is the reference
for each of the studied agents. The phytochemical analysis
indicated the presence of volatile compounds, mainly oxy-
genated mono- and sesquiterpenes, in addition to sesquiter-
pene hydrocarbons.Themajor compounds identified in each
selected bioactive fraction and EO were guaiol in Ag
4
, trans-
nerolidol in Bd
2
, thymol in Ls
3
, 1-decanol in Cs
4
, decanal
in C. sativum EO, and 𝛼-pinene in C. articulatus EO. These
compounds alone were proven to have antimicrobial activity
against gram-positive bacteria [20] and yeasts [12, 20] that
may affect the viability and/or matrix of biofilm.
The fractionation process adopted in this bioguided study
is well established in the literature [21, 22]. As the major
compounds identified are in accordance with other reports
[9, 12], we considered the fractionation process successful.
3.2. CLSM Analysis for S. mutans Biofilms. Confocal laser
scanningmicroscopy is a useful tool for studyingmorphology
of bacterial biofilms [23], as it allows 3D visualization of
hydrated and undisturbed biofilms [24].
To the best of our knowledge, this is the first confocal
study in the literature determining the effect of these bioactive
fractions from EO on the biovolume and architecture of
S. mutans biofilms. Overall, confocal imaging revealed that
most experimental samples at the given concentrations pro-
duced both qualitative (Figure 1) and quantitative (Table 4)
alterations in the biofilms. However, the analysis of the
intacttreated biofilms showed no statistical difference for
thickness in all groups compared to the control (vehicle) (𝑃 >
0.05), as seen in Figure 2.
Table 4 brings themean (±SD) values of biovolumeof 72 h
S. mutans biofilms treated with the fractions. The biovolume
provides an estimation of biofilm biomass in relation to the
substratum area [19]. In our study, a significant reduction of
both EPS and bacterial cells was observed for Ag
4
and Ls
3
(𝑃 < 0.05) according to the COMSTAT analysis. The groups
Bd
2
and Cs
4
showed reduced levels of bacterial volume
but not of EPS. Therefore, our findings support the view
that the bioactive fractions of Ag
4
and Ls
3
disrupt biofilm
integrity and may have created porosity in the biofilm, as
there was no change in thickness but biomass of EPS and
bacteria was significantly reduced. This phenomenon could
potentially result in a weakened structure and affect the
biofilm dynamics, and this hypothesis may be a platform for
the development of new antimicrobial targets on biofilm-
dependent oral diseases such as caries, candidiasis, and
corelated ailments.
An association has been established between biofilm
formation and intrinsic resistance to antimicrobial stress [25],
which encourages the search for new active molecules with
the ability of disrupting biofilm structure.The harmful effects
of the fractions upon biofilm assembly that we observed
in our study could make the biofilm more susceptible to
the action of antimicrobial agents, considering the ease of
penetration and access to the cells of the basal layers. With
this perspective, synergism studies should be carried out to
investigate the combination of topical antibacterial agents,
for example, fluoride [21], with these fractions in order to
enhance the antimicrobial competence of both products.
As EO are composed of numerous chemical compounds,
their antimicrobial activity might be attributed to several
distinct mechanisms [8]. Briefly, we can point out that A.
gratissima and L. sidoides fractions had significant effects on
bacterial viability acting as bactericides [9] and also affected
a key feature of S. mutans pathogenicity, that is, production
of EPS [3].
Due to their hydrophobicity, EO molecules are able to
pass through the cell wall and penetrate fatty acid chains of
the phospholipid bilayer, rendering the cell membrane more
permeable and causing leakage of intracellular contents. Such
loss of cell homeostasis can culminate in lysis and cell death
[8]. This mechanism of action may justify the significant
decrease in biofilm cell population caused by the fractions in
relation to the vehicle.
EPS are an outstanding key-factor in biofilm formation
being produced by glycosyltransferases [26]. The fractions
from A. gratissima and L. sidoides reduced its amount,
indicating that one of their putative mechanisms of action
might be related to the inhibition of glycosyltransferase
activity.
Our coverage (EPS/bacteria) data (Figure 2) demonstrate
that, in all groups, the EPS matrix was found interspersed
between the bacterial cells. Biofilm distribution was assessed
by measuring the percentage of coverage of the substrate by
EPS and bacteria [19].
3.3. CLSM Analysis for C. albicans Biofilms. In previous
studies, C. sativum [11] and C. articulatus [10] have stood out
for their promising anti-Candida activity. We reported that
C. sativum EO, rich in decanal and trans-2-decenal (major
compounds), has strong fungicidal effects against Candida
albicans and non-albicans and acts by binding to membrane
ergosterol, which increases ionic permeability and leads to
cell death. This is the same mechanism of action of polyenes
such as nystatin and amphotericin B [27]. C. articulatus
presents antifungal properties due to constituents such as
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Figure 1: 2D confocal imaging: a qualitative analysis. Confocal image stacks of 72-h S. mutans UA 159 biofilms following topical treatment
with (a) A. gratissima: fraction Ag
4
; (b) B. dracunculifolia: fraction Bd
2
; (c) C. sativum: fraction Cs
4
; (d) L. sidoides: fraction Ls
3
; and (e)
vehicle (propylene glycol, 6.25% v/v).The structures depicted in red (Dextran, Alexa Fluor 6) represent the extracellular polysaccharides that
constitute the biofilm matrix, while the structures depicted in green (Syto 9) are metabolically active bacterial cells (optical magnitude 63x).
It can be noted that all bioactive fractions ((a)–(d)) affected the EPS matrix making it less intimately interspersed between and over the cells
than did the vehicle alone (e).
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Figure 2: 3D confocal imaging: a quantitative analysis. 3D reconstruction of confocal image stacks of 72-h S.mutansUA 159 biofilms following
topical treatment with A. gratissima: fraction Ag
4
; B. dracunculifolia: fraction Bd
2
; C. sativum: fraction Cs
4
; L. sidoides: fraction Ls
3
; and
vehicle (propylene glycol, 6.25% v/v). The structures depicted in red (Dextran, Alexa Fluor 6) represent the extracellular polysaccharides
that constitute the biofilm matrix, while the structures depicted in green (Syto 9) are metabolically active bacterial cells (optical magnitude
63x). The mean (±SD) of biofilm thickness (𝑧) in each group is indicated below the orthogonal images. There were no statistically
significant differences in thickness between the groups and the vehicle (𝑃 > 0.05, One-way ANOVA with Dunnett’s posttest). Our coverage
(EPS/bacteria) data demonstrate that in all groups the exopolysaccharide matrix was found interspersed between the bacterial cells. Coverage
percent represents the percentage of area occupied by bacteria or EPS in each of the CLSM optical section [30].
𝛼-pinene (major compound) that could be able to destroy
cell integrity and inhibit respiration and the ion transport
processes, leading to cell death [28].
Both C. sativum and C. articulatus EO inhibited yeast
biofilm adherence onto a polystyrene substrate from
62.5 𝜇g/mL [11] and 1.95 𝜇g/mL [10], respectively. It has
also been found that the EO from these species are more
effective against Candida spp. than their fractions either
on planktonic or biofilm cultures [9, 11, 12]; that is why we
decided to carry out the tests using only the EO, taking into
account costs of fractionation and biological activity.
In our study, confocal microscopy revealed that both OE
altered the viability of yeast cells compared to the vehicle
(Figure 3), most notably C. sativum EO (Figure 3(d)), which
substantially decreased the metabolic activity of the fungal
cells. Based on these and other results, C. sativum EO
emerges as a promising candidate for nonclinical and clinical
toxicology testing for the development of new drugs to treat
denture-related oral candidiasis.
The treatment with C. sativum EO (Figure 3(d)) affected
the viability of yeasts as much as did the standard antifungal
currently employed in dental practice (Figure 3(b)). This
finding is interesting if one compares an EO (complex
mixture of chemical compounds) classified as food in Brazil
and worldwide as GRAS (generally regarded as safe) [29]
with a synthetic monodrug (nystatin), and this may justify
the ethnopharmacology of the popular use of coriander as
a rinse to control denture-related atrophic candidiasis (folk
medicine).
4. Conclusion
The bioactive fractions from A. gratissima and L. sidoides
significantly reduced the biovolume of extracellular polysac-
charides and bacterial cells in the S. mutans biofilm model
used, but there was no difference with regard to biofilm
thickness. Taken together, our findings support the view
that these fractions disrupt biofilm integrity and may have
created porosity in the biofilm, as biomass decreased but
thickness was unaltered. Furthermore, C. sativum EO dras-
tically affected the viability of C. albicans cells. These results
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Figure 3: Inhibitory effects on Candida biofilm. 2D confocal imaging of C. albicans CBS 562 biofilm treated with (a) vehicle (propylene
glycol, 6.25% v/v); (b) standard antifungal (nystatin); (c) C. articulatus crude oil; and (d) C. sativum crude oil. The structures depicted in
green (Concanavalin A, Alexa Fluor 488 Conjugate) represent the yeast cell wall and those depicted in yellow (FUN 1 Cell Stain) are nonviable
cells, metabolically inactive (arrow 2). The viable cells, in turn, convert the dye FUN-1 to red fluorescent aggregates (arrow 1) (40x optical
magnitude). Concanavalin A selectively binds to polysaccharides, including alpha-mannopyranosyl and alpha-glucopyranosyl residues, and
gives a green fluorescence. FUN-1 is a fluorescent dye taken up by yeast cells; in the presence of metabolic viability it is converted from a
diffuse yellow cytoplasmic stain to red [15]. It can be noted that C. sativum essential oil drastically affected the viability of C. albicans cells
when compared to the vehicle and standard antifungal.
highlight the promising antimicrobial activity of these plant
species and suggest avenues for future translational research
on the treatment of dental caries and oral candidiasis.
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